Human immunodeficiency virus type 1 (HIV-1), the causative agent for AIDS, is a cytopathic retrovirus in the lentivirus family with tropism for T lymphocytes (3, 16, 25) . Studies have convincingly demonstrated that CD4 is the cell membrane receptor for HIV-1 (12, 21, 27) . Extensive genetic analyses have been performed to define the regions of CD4 (2, 4, 20, 23, 28, 30) and gpl20 (22, 24) required for their interaction. The gpl20-binding domain of CD4 has been localized to the N-terminal region of the molecule.
Several groups (9, 13, 15, 19, 33) , including our own (6, 32) , have expressed soluble recombinant forms of CD4 (rCD4) and have demonstrated the ability of rCD4 to inhibit HIV-1 infection in vitro. Pharmacologic and functionally improved versions of the recombinant receptor, called immunoadhesins, were produced by combining the gpl20-binding N-terminal domains of CD4 with the immunoglobulin Gl (IgGl) heavy chain Fc region (5, 8) or heavy chain of IgM (34) . To further define the properties of rCD4 and CD4-IgG, we have studied their abilities to inhibit syncytium formation between HIV-infected and uninfected cells.
Inhibition of HIV-1 syncytium formation. By using a protocol based on that of Hildreth and Orentas (17), we examined the effects of rCD4 on formation of syncytia between H9 cells chronically infected with HIV-lIIIB and C8166 cells, a human T-cell line previously shown to be highly susceptible to HIV-induced fusion (10, 31 Concentrations of 10 ,ug of rCD4 per ml showed partial inhibition of syncytium formation, measured by either an increase in viable cell number or a microscopic morphological observation; 100 ,ug of rCD4 per ml showed complete inhibition ( Fig. 1 and 2 ). Mixtures of C8166 cells and uninfected H9 cells showed no syncytium formation (Fig.  2C) . rCD4 had no effect on viability of either uninfected H9 or C8166 cells. Similarly, mixtures of C8166 cells and CEM cells chronically infected by HIV-lIIIB, HIV-1AL (18), HIV-lRJ906, or HIV-lRJ4029 (6) were also tested, and rCD4 completely prevented syncytium formation, though at slightly different concentrations (results not shown).
Failure of rCD4 to inhibit HIV-2-mediated syncytium formation. Under the same experimental conditions, mixtures of C8166 cells and H9 cells chronically infected with HIV-2ROD (11) showed substantially different results ( Fig. 1  and 3 ). When C8166 cells and HIV-2ROD-H9 cells were mixed in control medium, rapid appearance of syncytia was observed. These syncytia were larger and appeared somewhat more rapidly than those observed with the HIV-1 strains. Addition of rCD4 to the C8166 plus HIV-2ROD-H9 mixtures failed to block syncytium formation. Cell mixtures containing rCD4 concentrations greater than 0.1 ,ug/ml actually showed an increase in syncytium formation, with respect to both the size of the giant cells and the number of cells in the culture that were included in the giant cells (Fig.  3) .
Comparison of the effects of rCD4, CD4-IgG, and proteolytically derived fragments of CD4-IgG on HIV-1-and HIV-2-mediated syncytium formation. We next measured the ability Concentration of rCD4 (jug/ml) Capon, and A. Ashkenazi, Biochemistry, in press).
As was observed for rCD4, when V1V2-CD4 fragments were added to mixtures of C8166 cells and HIV-2ROD-H9 cells, no inhibition of HIV-2-mediated syncytia was seen and an increase in rate and size of giant cell formation was observed ( Fig. 3 and 4 ). Purified Fc fragment had no effect on syncytium formation, and equimolar mixtures of Fc fragments and V1V2-CD4 fragments yielded results similar to those obtained with the V1V2-CD4 fragment alone (Table 1) . Taken together, these observations suggest that the ability of CD4-IgG to block syncytium formation is due to its bivalent nature. It is still possible, however, that the Fc portion of CD4-IgG may interact with the CD4 domains in some functionally significant manner. Our observation that rCD4 enhanced HIV-2-mediated syncytium formation, especially at high rCD4 concentrations, was unexpected. Our previous experiments (6) and those of Clapham et al. (9) and Watanabe et al. (35) had suggested that the interaction of CD4 with the HIV-2 or simian immunodeficiency virus envelope glycoproteins was of a lower affinity than that of CD4 with gpl20 of HIV-1. A lower affinity of HIV-2 gpl20, relative to that of HIV-1, for rCD4 could in part explain the failure of rCD4 to inhibit HIV-2-mediated syncytium formation; however, it does not explain the increased HIV-2-mediated syncytium formation observed in these studies. HIV-2-mediated fusion may involve the interaction of HIV-2 envelope proteins with molecules on the target cell surface other than CD4. These additional interactions may not be blocked by rCD4. Cell surface structures such as the adhesion proteins, particularly LFA-1 (17) , or major histocompatibility complex class II molecules are involved in cellular interactions (14) , though no interactions with soluble CD4 have been reported to date (19, 26) . It is also possible that the interaction of rCD4 with gpl20 of HIV-2 may expose or activate domains of gp4l important in the fusion process, and the mobility of gpl2O-gp4l in the membrane may be important in this process. The observed differences between HIV-1-and HIV-2-mediated cell fusion suggest that there may be fundamental differences in the processes by which these viruses fuse with target cells.
Since the completion of these experiments, Allan et Fig. 2 and 3 . Enhancement is defined as syncytium formation greater than that seen in media control wells for the same virus-infected cell type. The extent of syncytium formation and enhancement was scored on a scale from -(none) to + + + + (maximum).
noadhesins may have unexpected antiviral properties and supports the continued exploration of this novel class of antiviral agents.
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